ten23 health and BD have initiated collaborations to develop a new tracking system for prefillable syringes.
The CDMO and medical technology company will together pilot BD’s RFID-based solution to enhance the efficiency of pre-filled injectable manufacturing.
BD’s tech will also aim to optimise the traceability of the injectable supply chain, as well as the manufacturing processes associated with this drug type.
The novel solution has been named iDFill Individual Prefillable Syringe Identification, and uses a Container Unique Identifier to pull up an injectable’s drug code, filling batch and associated timestamps — allowing for full container traceability.
BD Medical’s President of Pharmaceutical Systems, Patrick Jeukenne, commented: “BD iDFill aims to transform the way we approach quality and efficiency in the fill & finish process by extending the role of the PFS from a drug container to a digital enabler,”
“We expect this innovation will harness the vast potential of data in manufacturing and bring a new level of transparency to the pharmaceutical fill & finish process.”
CSO of CDMO ten23 health, Andrea Allmendinger, added: “This new RFID-based traceability solution has the potential to further enhance our manufacturing processes and also provides significant benefits to our pharmaceutical customers by ensuring greater transparency and reducing risks.”
BD and ten23 health join forces to optimise aseptic injectable manufacturing
The companies will track prefillable syringes using radio frequency identification (RFID) technology to boost supply chain visibility
